About PreviPharma
PreviPharma is an Agriculture company based in Mannheim (Germany) founded in 2015. It provides research and development services for plasma fractionation and industry partnerships. It operates on a B2B and Service-based Consulting model in Agriculture and Healthcare sectors. Its Indian entity Previpharma India Private Limited reported revenue of ₹1.61 Cr. PreviPharma offers products and services including Research Services and Accelerated Candidate Development. Its focus areas include Biotechnology, Plasma Fractionation, R&D Services and Pharmaceuticals.
Company details
PreviPharma Consulting GmbH is a leading partner in the plasma fractionation industry, offering specialized knowledge and resources for projects across the RD supply chain. They deliver tailored research services, including accelerated candidate development, using advanced facilities and networks. Based in Mannheim, Germany, they support clients in pharmaceuticals with comprehensive solutions from discovery to life cycle management, fostering innovation through expertise and collaborations.
- Headquarters Mannheim, Germany
- SectorsAgricultureHealthcare
- Email••••••••
- Website previpharma.com
- Legal Name Previpharma India Private Limited
- Date of Incorporation 10 Oct, 2023
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹1.61 Cr
FY 2025 · +99% YoY
- Indian entity net profit₹21.1 Lakh
FY 2025 · 13% margin
- Indian entity EBITDA₹30.3 Lakh
FY 2025 · 19% margin
Associated legal entities of PreviPharma
PreviPharma operates through Previpharma India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Previpharma India Private Limited CIN U46497TS2023PTC177885 | Active | 10 Oct 2023 | Hyderabad, Telangana | ₹1.6 Cr | 3 | View details |
Products & Services of PreviPharma
PreviPharma offers a comprehensive portfolio of products and services, including Research Services and Accelerated Candidate Development.
Provides expertise in plasma fractionation R&D and supply chain support.
Speeds up development processes for pharmaceutical candidates.
Board of directors of Previpharma India Private Limited (PreviPharma)
Previpharma India Private Limited is the primary company behind PreviPharma. The board of Previpharma India Private Limited currently have 3 directors; the longest-serving is Gadda Sai Vijay Kumar, appointed in 2023.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gadda Sai Vijay Kumar DIN 10348989 | Director | 10 Oct 2023 | 3 yrs | Previpharma India Private Limited |
| Marc Mazur Michael DIN 10348988 | Director | 10 Oct 2023 | 3 yrs | Previpharma India Private Limited |
| Satish Kumar Devarapu DIN 10443294 | Director | 28 Dec 2023 | 2 yrs 9 mo | Previpharma India Private Limited |
Financials of PreviPharma
Figures of Previpharma India Private Limited, the primary company behind PreviPharma, for FY 2025. Revenue was ₹1.61 Cr (+99% year on year). Net profit was ₹21.1 Lakh (13% margin). EBITDA was ₹30.3 Lakh (19% margin).
- ₹1.61 CrRevenue · FY 2025 · +99% YoY
- ₹21.1 LakhNet profit · 13% margin
- ₹30.3 LakhEBITDA · 19% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Previpharma India Private Limited are on its company page.
Detailed financial statements for PreviPharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PreviPharma
PreviPharma was founded in 2015.
PreviPharma is headquartered in Mannheim, Germany. It is registered at Mannheim, Baden-wurttemberg, Germany.
The primary company behind PreviPharma, Previpharma India Private Limited, reported revenue of ₹1.61 Cr for FY 2025, up 99% year on year.
PreviPharma Consulting GmbH is a leading partner in the plasma fractionation industry, offering specialized knowledge and resources for projects across the RD supply chain. They deliver tailored research services, including accelerated candidate development, using advanced facilities and networks. Based in Mannheim, Germany, they support clients in pharmaceuticals with comprehensive solutions from discovery to life cycle management, fostering innovation through expertise and collaborations.
PreviPharma offers Research Services and Accelerated Candidate Development.
PreviPharma operates through Previpharma India Private Limited.
The legal entities of PreviPharma currently have 3 directors, including Satish Kumar Devarapu, Gadda Sai Vijay Kumar, Marc Mazur Michael.